Patents Assigned to Humanetic Corp.
  • Use of ?5-androstene-3?-ol-7,17-dione in the treatment of lupus erythematosus
    Patent number: 6924274
    Abstract: Lupus erythematosus can be treated by administering therapeutic amounts of ?5-androstene-3?-ol-7,17-dione and metabolizable precursors thereof, such as ?5-androstene-3b-acetoxy-7,17-dione, which are readily metabolized in vivo to ?5-androstene-3?-ol-7,17-dione but are not appreciably metabolizable in vivo to androgens, estrogens or dehydroepiandrosterone. Such treatment can be prophylactic, ameliorative or curative in nature.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: August 2, 2005
    Assignee: Humanetic Corp.
    Inventors: Henry A. Lardy, Charles E. Weeks